Clinical Trials Directory

Trials / Completed

CompletedNCT02404402

LED Treatment to Improve Cognition and Promote Recovery in TBI

Noninvasive LED Treatment to Improve Cognition and Promote Recovery in Blast TBI

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
VA Office of Research and Development · Federal
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Not accepted

Summary

This study investigates the efficacy of a novel neuromodulation treatment, light emitting diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with traumatic brain injury (TBI).

Detailed description

The most common traumatic brain injury (TBI)-associated problems are cognitive deficits and neuropsychiatric problems, such as sleep disturbance and PTSD. This study evaluates a novel neuromodulation intervention, light emitting diodes (LED), for treatment of patients with TBI. LED is a noninvasive, non-thermal, painless treatment, which does not involve any needles or any form of surgery. LED treatment improves cellular activity of the brain tissue that has been damaged by TBI. Half of the study participants will receive active LED treatment, and a control group will receive sham LED. This study takes place in Boston, Massachusetts: at the VA Boston Healthcare System.

Conditions

Interventions

TypeNameDescription
OTHERLEDLow Level Light Therapy
OTHERsham LEDInactive (sham) LED treatment

Timeline

Start date
2015-05-01
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2015-03-31
Last updated
2026-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02404402. Inclusion in this directory is not an endorsement.